Effect of diet and physical activity on physiological and biochemical parameters of obese adolescents;Wplstockyw diety i aktywności fizycznej na poprawe parametrów biochemicznych i fizjologicznych u otylstockych chlopców

Acta Scientiarum Polonorum, Technologia Alimentaria

Volumn 9, Issue 1, 2010, Pages 95-104

  Kasprzak, Zbigniew ^a   Pilaczyńska Szcześniak, Łucja ^a  

^a University of Physical Education in Poznan   (Poland)

Author keywords

Blood lipidograme; Diet; Obesity; Physical activity

Indexed keywords

ADIPOSE TISSUE; ANTHROPOMETRIC MEASUREMENT; BIOCHEMICAL PARAMETERS; BODY MASS; CARBOHYDRATE METABOLISM; CARDIO-VASCULAR DISEASE; DIET; LIPID PROFILE; LOW ENERGIES; OBESITY; PHYSICAL ACTIVITY; POSITIVE CHANGES; SERUM INSULIN; TRIACYLGLYCEROLS; TYPE II; VASCULAR DISEASE; WEIGHT REDUCTION;

ANTHROPOMETRY; BLOOD; CARBOHYDRATES; CHOLESTEROL; GLUCOSE; GLYCEROL; INSULIN; PHYSIOLOGICAL MODELS;

NUTRITION;

EID: 77955704161     PISSN: 16440730     EISSN: 18989594     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ästrand P.O., Rhyming I., 1954. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during submaximal work. J. Appl. Physiol. 9, 2-8.
2. Ball S., 2005. Zespół metaboliczny w otyłości i nadwadze [Metabolic syndrome in obesity and overweight]. Wyd. Medyk Warszawa [in Polish].
3. Baron A., Wallace D., Brechtel G., 1987. In vivo regulation of non-insulin mediated and insulin mediated glucose uptake by cortisol. Diabets 36, 1230-1237.
4. Björntorp P., 1996. The regulation of adipose tissue distribution in humans. Int. J. Obes. Relat. Metab. Dis. 20, 291-302.
5. Bobilewicz D., 1961. Metody rozdziału frakcji lipoproteinowych [Methods separation of lipoprotein faction]. Cormay-Diagnostyka 1, 4-5 [in Polish].
6. Bray G.A., 1995. Life insurance and overweight. Obes. Res. 3, 97-99.
7. Cybulska B., 2000. Aterogenna dyslipidemia [Aterogenic dyslipidemia]. Medycyna po dyplomie 3-4, 39-43 [in Polish].
8. Cybulska B., Szostak W., 1995. Otyłość wisceralna jako czynnik zagrożenia choroba{ogonek} niedokrwienna{ogonek} serca [Visceral obesity as the factor of the Cardiovascular disease risk]. Pol. Tyg. Lek. Supl. 1, 43-47 [in Polish].
9. DeFronzo R., Gunnarsson R., Bjorkman O., Olsson M., Wahren J., 1985. Effect of insulin on peripherial and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 76, 149-155.
10. Ferguson M., Gutin B., Le N., Karp W., Litaker M., Humphries M., Okuyama T., Riggs S., Owens S., 1999. Effect of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int. J. Obes. Relat. Metab. Dis. 23, 889-895.
11. Ferrannini E., Camastra S., 1998. Relationship between impaired glucose tolerance, non-insulin dependent diabetes mellitus and obesity. Eur. J. Clin. Invest. 28 (suppl 2), 3-7.
12. Gibney M., 1999. Nutrition, physical activity and health status in Europe: an overview. Publ. Health Nutr. 2, 329-333.
13. Goran M., Ball G., Cruz M., 2003. Obesity and risk of type 2diabetes and cardiovascular disease in children and adolescents. J. Clin. Endocrinol. Metab. 88, 417-1427.
14. Gutin B., Owens S., Okuyama T., Riggs S., Ferguson N., Litaker M., 1999. Effect of physical training and its cessation upon percent fat and bone density of obese children. Obes. Res. 7, 208-214.
15. Hardman A., 1999. Physical activity, obesity and blood lipids. Int. Obes. Relat. Metab. Dis. 23 (suppl 3), 64-71.
16. Harris T., Gook E., Garrison R., Higgins M., Kannel W., Goldman L., 1988. Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. JAMA 259, 1520-1524.
17. Hasselwander O., McEneny J., Mcmaster D., Fogarty D., Nicholls D., Maxwell A., Young I., 1999. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. Atherosclerosis 143, 125-133.
18. Hokanson J., Austin M., 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk 3, 213-229.
19. Hughes V., Fiatarone M., Fielding R., Kaahn B., 1993. Exercis increase muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am. J. Physiol. 264, E855-E862.
20. Inoue T., Uchida T., Kamishirado H., Takayanagi K., Hayashi T., Morooka S., 2001. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J. Am. Coll. Cardiol. 37, 555-559.
21. Iskra M., Pioruńska-Stolzman M., 2001. Przeciwutleniaja{ogonek}ce właściwości lipoprotein o wysokiej ge{ogonek}stości i ich zmiana w reakcji ostrej fazy [Antioxidant properties of lipoprotein the high density and their change in reaction of the acute phase]. Czyn. Ryz. 3-4, 11-18 [in Polish].
22. Jeppesen J., Hein H., Suadicani P., Gyntelberg F., 1998. Triglycerides concentration and ischemic heart disease. An eight-year follow up in the Copenhagen Male Study. Circulation 97, 1029-1036.
23. Kasprzak Z., Szcze{ogonek}śniak Ł., Rychlewski T., 1995. Wpływ systematycznego wysiłku fizycznego oraz niskoenergetycznej diety na zachowanie sie{ogonek} parametrów antropometrycznych i fizjologicznych u dzieci z otyłościa{ogonek} prosta{ogonek} [Influence of a systematic physical exercise and low-energy diet on behaving of anthropometric and physiological parameters at children with the simple obesity]. Diabetol. Pol. 2, 42-48 [in Polish].
24. Katz A., Broberg S., Sahlin K., Wahern J., 1986. Leg glucose uptake during maximal dynamic exercise in humans. Am. J. Physiol. 251, E65-E70.
25. Kromhout D., Menotti A., Bloemberg B., Aravanis C., 1995. Dietary saturated and trans fatty acids and cholesterol and 25-years mortality from coronary heart disease: the Seven Country Study. Prev. Med. 24, 308-315.
26. Lenart-Domka E., Kwolek A., 2007. Rehabilitacja dzieci otyłych - czy jest rzeczywiście potrzebna? [Rehabilitation of obese children - whether is really needed]. Przegl. Med. Uniw. Rzesz., 99-105 [in Polish].
27. Levini G., Keaney J., Vita J., 1995. Cholesterol reduction in cardiovascular disease: clinical benefis and possible mechanism. N. Engl. J. Med. 332(8), 512-521.
28. Miller W., Lindemann A., Wallace J., Niederpruem M., 1990. Diet composition, energy intake and exercise in relation to body fat in man and women. Am. J. Clin. Nutr. 52, 426-430.
29. Nazar K., Kaciuba-Uściłko H., 1995. Aktywność ruchowa w zapobieganiu i leczeniu otyłości [Physical exercise in prevention and treatment obesity]. Pol. Tyg. Lek. 50, Supl. 1, 68-69 [in Polish].
30. Niemiec A., Franek E., Kokot F., 2001. Wpływ odchudzania na oś leptyna-neuropeptyd Y u osób otyłych z cukrzyca{ogonek} i bez cukrzycy [Influence of reduction of body mass on the axis leptin-neuropeptide Y at obese persons with diabetes and without diabetes]. Med. Metabol. 1, 18-26 [in Polish].
31. Peiris A., Sothmann M., Hennes M., Lee M., Wilson C., Gustafson A., Kissebah A., 1989. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women. Am. J. Clin. Nutr. 49, 758-760.
32. Pietinen P., Vartiainen E., Seppanen R., 1996. Changes in diet in Finland from 1972 to 1992: impact of coronary heart disease risk. Prev. Med. 25, 243-250.
33. Reaven G., 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
34. Rimm E., Ascherio A., Giovannucci E., Spiegelman D., Stampfer M., Willett W., 1996. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 275, 447-541.
35. Ruan H., Lodish H., 2003. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Fact. Rev. 14, 447-455.
36. Rybakowa M., 1993. Zaburzenia w odżywianiu. Otyłość [Disorders of feeding. Obesity]. In: Zaburzenia hormonalne u dzieci i młodzieży. Ed. T.E. Romer. Omnitech Press Warszawa 353-355 [in Polish].
37. 125I-insulin by receptors on erythrocytes as well as on insulin and C-peptide serum levels in patients after myocardial infarction and healthy individuals. J. Physiol. Pharmacol. 48, 4, 839- -849.
38. Steinberg D., 1997. Low density lipoprotein oxidation and its pathological significance. J. Biol. Chem. 272, 20963-20966.
39. Szczeklik-Kumala Z., Czech A., Łaz R., Jagielinska-Kalinowska E., Bernas M., Tatoń J., 2002. Epidemiologia aterogennych zaburzeń składu lipidów krwi w zdefiniowanej populacji [Epidemiology of aterogenic disorders of the composition of lipides in blood of the defined population]. Med. Metabol. 6, 1, 12-20 [in Polish].
40. Szcześniak L., Rychlewski T., Kasprzak Z., Banaszak F., 1997. Insulinemia and insulin resistance in obesity-the influence of systematic physical effort. Ann. Diagn. Pediatr. Pathol. 1 (3), 220.
41. Taylor R., Husband D., Marshal S., et al., 1984. Adipocyte insulin binding and insulin sensivity in "britte" diabetes. Diabetol. 27, 441-446.
42. Westerterp K., 1999. Obesity and physical activity. Int. Obes. Relat Metab. Disord. 23 (suppl. 1), 59-64.